Spectrum of Spondyloarthritis Among Chinese Populations

Purpose of Review This review aims to emphasize interesting and important new findings with a focus on the spectrum of spondyloarthritis (SpA) in China. Recent Findings Over the past decade, significant advances have been made in the investigation of SpA epidemiology, the exploration of genetic and...

Full description

Saved in:
Bibliographic Details
Published inCurrent rheumatology reports Vol. 24; no. 8; pp. 247 - 258
Main Authors Zhang, Shangzhu, Peng, Linyi, Li, Qingyang, Zhao, Jinwei, Xu, Dong, Zhao, Jiuliang, Wang, Qian, Li, Mengtao, Zhang, Wen, Tian, Xinping, Su, Jinmei, Zeng, Xiaofeng
Format Journal Article
LanguageEnglish
Published New York Springer US 01.08.2022
Subjects
Arthritis, Psoriatic - drug therapy
Arthritis, Psoriatic - epidemiology
Arthritis, Psoriatic - genetics
Ethnicity
HLA-A Antigens - therapeutic use
HLA-B27 Antigen - genetics
Humans
Medicine
Medicine & Public Health
Rheumatology
Section Editors
Spondylarthritis - drug therapy
Spondylarthritis - epidemiology
Spondylarthritis - genetics
Spondylitis, Ankylosing - drug therapy
Spondylitis, Ankylosing - epidemiology
Spondylitis, Ankylosing - genetics
Spondyloarthritis (MA Khan and N Akkoc
Spondyloarthritis (MA Khan and N Akkoc, Section Editors
Topical Collection on Spondyloarthritis
Treatment
Enteropathic SpA
Chinese
Spondyloarthritis
HLA-B27
Epidemiology
Ankylosing spondylitis
Juvenile idiopathic arthritis
Psoriatic arthritis
Online AccessGet full text

Cover

Abstract Purpose of Review This review aims to emphasize interesting and important new findings with a focus on the spectrum of spondyloarthritis (SpA) in China. Recent Findings Over the past decade, significant advances have been made in the investigation of SpA epidemiology, the exploration of genetic and environmental risk factors, the identification of clinical features, and the updating of treatment protocols in the Chinese population. The prevalence of ankylosing spondylitis (AS) in China is 0.20–0.42%, and the prevalence of HLA-B27 in AS patients is 88.8–89.4%. HLA-B*2704 is the most common subtype in Chinese AS patients, followed by HLA-B*2705. HLA-A*01, more precisely HLA-A*01:01, may be associated with psoriatic arthritis (PsA). Tumor necrosis factor inhibitors and IL-17A inhibitors have been shown to be effective and safe for AS patients in China. Juvenile-onset AS is relatively rare, accounting for only 9.1% of the AS population. The prevalence of arthritis related to inflammatory bowel disease is 6.9 to 7.2%. A Chinese study showed that the most frequently prescribed medication was methotrexate (66.4%). Biological agents were prescribed in only16.4% of patients with PsA. Summary This review summarizes the latest research in the epidemiology, pathogenesis, clinical manifestations, and management of SpA among Chinese populations. Multiple HLA associations with SpA have also been described, and it is hoped that discoveries of such ethnic-specific risk factor(s) and understanding of their pathological mechanisms may potentially lead to newer targeted therapies for the Chinese populations worldwide.
AbstractList This review aims to emphasize interesting and important new findings with a focus on the spectrum of spondyloarthritis (SpA) in China.PURPOSE OF REVIEWThis review aims to emphasize interesting and important new findings with a focus on the spectrum of spondyloarthritis (SpA) in China.Over the past decade, significant advances have been made in the investigation of SpA epidemiology, the exploration of genetic and environmental risk factors, the identification of clinical features, and the updating of treatment protocols in the Chinese population. The prevalence of ankylosing spondylitis (AS) in China is 0.20-0.42%, and the prevalence of HLA-B27 in AS patients is 88.8-89.4%. HLA-B*2704 is the most common subtype in Chinese AS patients, followed by HLA-B*2705. HLA-A*01, more precisely HLA-A*01:01, may be associated with psoriatic arthritis (PsA). Tumor necrosis factor inhibitors and IL-17A inhibitors have been shown to be effective and safe for AS patients in China. Juvenile-onset AS is relatively rare, accounting for only 9.1% of the AS population. The prevalence of arthritis related to inflammatory bowel disease is 6.9 to 7.2%. A Chinese study showed that the most frequently prescribed medication was methotrexate (66.4%). Biological agents were prescribed in only16.4% of patients with PsA. This review summarizes the latest research in the epidemiology, pathogenesis, clinical manifestations, and management of SpA among Chinese populations. Multiple HLA associations with SpA have also been described, and it is hoped that discoveries of such ethnic-specific risk factor(s) and understanding of their pathological mechanisms may potentially lead to newer targeted therapies for the Chinese populations worldwide.RECENT FINDINGSOver the past decade, significant advances have been made in the investigation of SpA epidemiology, the exploration of genetic and environmental risk factors, the identification of clinical features, and the updating of treatment protocols in the Chinese population. The prevalence of ankylosing spondylitis (AS) in China is 0.20-0.42%, and the prevalence of HLA-B27 in AS patients is 88.8-89.4%. HLA-B*2704 is the most common subtype in Chinese AS patients, followed by HLA-B*2705. HLA-A*01, more precisely HLA-A*01:01, may be associated with psoriatic arthritis (PsA). Tumor necrosis factor inhibitors and IL-17A inhibitors have been shown to be effective and safe for AS patients in China. Juvenile-onset AS is relatively rare, accounting for only 9.1% of the AS population. The prevalence of arthritis related to inflammatory bowel disease is 6.9 to 7.2%. A Chinese study showed that the most frequently prescribed medication was methotrexate (66.4%). Biological agents were prescribed in only16.4% of patients with PsA. This review summarizes the latest research in the epidemiology, pathogenesis, clinical manifestations, and management of SpA among Chinese populations. Multiple HLA associations with SpA have also been described, and it is hoped that discoveries of such ethnic-specific risk factor(s) and understanding of their pathological mechanisms may potentially lead to newer targeted therapies for the Chinese populations worldwide.
Purpose of Review This review aims to emphasize interesting and important new findings with a focus on the spectrum of spondyloarthritis (SpA) in China. Recent Findings Over the past decade, significant advances have been made in the investigation of SpA epidemiology, the exploration of genetic and environmental risk factors, the identification of clinical features, and the updating of treatment protocols in the Chinese population. The prevalence of ankylosing spondylitis (AS) in China is 0.20–0.42%, and the prevalence of HLA-B27 in AS patients is 88.8–89.4%. HLA-B*2704 is the most common subtype in Chinese AS patients, followed by HLA-B*2705. HLA-A*01, more precisely HLA-A*01:01, may be associated with psoriatic arthritis (PsA). Tumor necrosis factor inhibitors and IL-17A inhibitors have been shown to be effective and safe for AS patients in China. Juvenile-onset AS is relatively rare, accounting for only 9.1% of the AS population. The prevalence of arthritis related to inflammatory bowel disease is 6.9 to 7.2%. A Chinese study showed that the most frequently prescribed medication was methotrexate (66.4%). Biological agents were prescribed in only16.4% of patients with PsA. Summary This review summarizes the latest research in the epidemiology, pathogenesis, clinical manifestations, and management of SpA among Chinese populations. Multiple HLA associations with SpA have also been described, and it is hoped that discoveries of such ethnic-specific risk factor(s) and understanding of their pathological mechanisms may potentially lead to newer targeted therapies for the Chinese populations worldwide.
This review aims to emphasize interesting and important new findings with a focus on the spectrum of spondyloarthritis (SpA) in China. Over the past decade, significant advances have been made in the investigation of SpA epidemiology, the exploration of genetic and environmental risk factors, the identification of clinical features, and the updating of treatment protocols in the Chinese population. The prevalence of ankylosing spondylitis (AS) in China is 0.20-0.42%, and the prevalence of HLA-B27 in AS patients is 88.8-89.4%. HLA-B*2704 is the most common subtype in Chinese AS patients, followed by HLA-B*2705. HLA-A*01, more precisely HLA-A*01:01, may be associated with psoriatic arthritis (PsA). Tumor necrosis factor inhibitors and IL-17A inhibitors have been shown to be effective and safe for AS patients in China. Juvenile-onset AS is relatively rare, accounting for only 9.1% of the AS population. The prevalence of arthritis related to inflammatory bowel disease is 6.9 to 7.2%. A Chinese study showed that the most frequently prescribed medication was methotrexate (66.4%). Biological agents were prescribed in only16.4% of patients with PsA. This review summarizes the latest research in the epidemiology, pathogenesis, clinical manifestations, and management of SpA among Chinese populations. Multiple HLA associations with SpA have also been described, and it is hoped that discoveries of such ethnic-specific risk factor(s) and understanding of their pathological mechanisms may potentially lead to newer targeted therapies for the Chinese populations worldwide.
Author Peng, Linyi
Tian, Xinping
Zhang, Shangzhu
Zhao, Jinwei
Li, Mengtao
Zeng, Xiaofeng
Wang, Qian
Su, Jinmei
Xu, Dong
Li, Qingyang
Zhang, Wen
Zhao, Jiuliang
Author_xml – sequence: 1
  givenname: Shangzhu
  surname: Zhang
  fullname: Zhang, Shangzhu
  organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education
– sequence: 2
  givenname: Linyi
  surname: Peng
  fullname: Peng, Linyi
  organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education
– sequence: 3
  givenname: Qingyang
  surname: Li
  fullname: Li, Qingyang
  organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education
– sequence: 4
  givenname: Jinwei
  surname: Zhao
  fullname: Zhao, Jinwei
  organization: National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology
– sequence: 5
  givenname: Dong
  surname: Xu
  fullname: Xu, Dong
  organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education
– sequence: 6
  givenname: Jiuliang
  surname: Zhao
  fullname: Zhao, Jiuliang
  organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education
– sequence: 7
  givenname: Qian
  surname: Wang
  fullname: Wang, Qian
  organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education
– sequence: 8
  givenname: Mengtao
  surname: Li
  fullname: Li, Mengtao
  organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education
– sequence: 9
  givenname: Wen
  surname: Zhang
  fullname: Zhang, Wen
  organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education
– sequence: 10
  givenname: Xinping
  surname: Tian
  fullname: Tian, Xinping
  organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education
– sequence: 11
  givenname: Jinmei
  orcidid: 0000-0003-3560-2004
  surname: Su
  fullname: Su, Jinmei
  email: jinmei.su@cstar.org.cn
  organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education
– sequence: 12
  givenname: Xiaofeng
  surname: Zeng
  fullname: Zeng, Xiaofeng
  email: zengxfpumc@163.com
  organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35829981$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtLxDAcxIMoPla_gAfp0Uv1n0eb5iLI4gsWFFbPIZumu5E2qUkr-O3NuirqwVMCmd8MmTlA2847g9AxhjMMwM8jxoKUORCSAwYucryF9nFBWV5S4NvrO6E55ZztoYMYnwEIQEV30R4tKiJEhfcRn_dGD2HsMt9k8967-q31KgyrYAcbs8vOu2U2XVlnoskefD-2arDexUO006g2mqPPc4Kerq8ep7f57P7mbno5y3WByZAvABSrwVSmAKXrgummFAoTzXjNTbVgXDfQMAYLignhguqqrgVvcMEwp4bQCbrY-PbjojO1Nm4IqpV9sJ0Kb9IrK3-_OLuSS_8qRaogfT8ZnH4aBP8ymjjIzkZt2lY548coSVkJKIoyxU3Qyc-s75CvtpKg2gh08DEG00hth48-UrRtJQa5HkZuhpFpGPkxjFyj5A_65f4vRDdQTGK3NEE--zG41Pd_1DvE7KCe
CitedBy_id crossref_primary_10_32725_jab_2025_004
crossref_primary_10_1016_j_intimp_2024_113984
crossref_primary_10_1016_j_jmoldx_2024_03_010
crossref_primary_10_1111_1346_8138_17123
crossref_primary_10_1007_s40259_023_00625_2
crossref_primary_10_1620_tjem_2023_J033
crossref_primary_10_1007_s40744_024_00688_9
crossref_primary_10_1111_1756_185X_14547
crossref_primary_10_1007_s11926_023_01118_5
crossref_primary_10_4049_immunohorizons_2400026
crossref_primary_10_1007_s40744_024_00646_5
crossref_primary_10_1080_10641963_2022_2156529
crossref_primary_10_1111_1756_185X_15004
crossref_primary_10_1093_mr_road039
crossref_primary_10_20473_cimrj_v5i1_52842
crossref_primary_10_3389_fgene_2023_1129247
Cites_doi 10.1136/annrheumdis-2016-210770
10.3760/cma.j.issn.1008-1372.2007.01.025
10.1093/rheumatology/keaa464
10.1097/BOR.0b013e32834640a9
10.3969/j.issn.1671-2560.2006.04.007
10.1111/1756-185x.13094
10.3969/j.issn.2095-4174.2017.07.001
10.1007/s40744-021-00384-y
10.1016/s0140-6736(16)31591-4
10.1093/rheumatology/kep230
10.3969/j.issn.1004-583X.2021.06.003
10.1186/1471-2474-15-284
10.3760/cma.j.issn.0578-1426.2020.03.004
10.1007/s00296-020-04537-0
10.1136/annrheumdis-2012-202533
10.3321/j.issn:1673-8225.2005.39.003
10.1136/annrheumdis-2019-216362
10.1007/s40259-020-00408-z
10.1155/2015/594878
10.3969/g.issn.0253-9802.2011.03.003
10.3969/j.issn.1001-0025.2020.05.004
10.3760/cma.j.issn.0578-1426.2011.12.013
10.1002/art.21174
10.3969/j.issn.1008-1062.2005.10.015
10.1111/tan.12254
10.3389/fimmu.2020.578732
10.1002/art.39416
10.1007/s00296-002-0237-4
10.3760/cma.j.issn.1007-7480.2016.10.005
10.3969/j.issn.1006-5725.2008.08.074
10.1007/978-1-4419-0298-6_12
10.1007/s00296-016-3441-3
10.1136/annrheumdis-2013-203582
10.1002/acr.22512
10.1111/j.1399-0039.2009.01406.x
10.1093/rheumatology/keu132
10.1007/s00590-012-1035-7
10.3969/j.issn.1673-8705.2021.02.005
10.1016/j.berh.2014.10.001
10.55563/clinexprheumatol/a6bvty
10.1371/journal.pone.0138492
10.1016/s0140-6736(11)60071-8
10.3321/j.issn:1673-8225.2006.28.008
10.1097/maj.0b013e318294457f
10.1136/ard.30.2.138
10.1136/ard.2007.075754
10.1007/s00296-009-1148-4
10.1007/s10067-018-4016-3
10.1136/annrheumdis-2017-212457
10.1097/00002281-200107000-00007
10.1016/s1726-4901(09)70432-0
10.1136/ard.2011.151563
10.1177/0300060519853929
10.1371/journal.pone.0211946
10.3760/cma.j.cn114798-20200622-00742
10.3760/cma.j.issn.0376-2491.2019.11.003
10.1007/s00296-020-04678-2
10.12659/MSM.921055
10.1007/s00223-014-9867-2
10.1016/j.jaut.2019.102360
10.1080/09273948.2016.1188967
10.3899/jrheum.111031
10.1093/ecco-jcc/jjx126
10.1056/NEJMra1505557
10.3760/j:issn:1007-7480.2001.02.011
10.1097/CM9.0000000000001099
10.1007/s00403-019-01902-3
10.3906/sag-1306-64
10.3389/fimmu.2021.677957
10.1056/NEJMra1406182
10.1007/s11926-017-0640-1
10.1002/art.21577
10.1016/j.semarthrit.2007.01.003
10.3760/cma.j.c141217-20201127-00454
10.1093/rheumatology/kep348
10.1016/j.jbspin.2009.11.015
10.1016/j.intimp.2016.06.033
10.3109/03009740902978085
10.1001/jamadermatol.2018.5194
10.3899/jrheum.110687
10.1186/ar2368
10.12122/j.issn.1673-4254.2021.05.01
10.1097/CM9.0000000000001710
10.1080/03009742.2019.1616324
10.3899/jrheum.101102
10.3969/j.issn.1674-2257.2018.04.008
10.1007/s10067-017-3660-3
10.3321/j.issn:1000-2790.2008.18.017
10.3389/fgene.2021.671682
10.3760/j:issn:1007-7480.2004.10.011
10.1002/acr.22831
10.3969/j.issn.2095-4174.2019.10.008
10.1186/s13075-020-02148-5
10.1097/00002281-199507000-00001
10.1186/s13075-016-1093-z
10.3389/fmed.2020.609562
10.3969/j.issn.2095-3720.2013.03.022
10.1111/hic3.12079
10.1186/s13075-018-1724-7
10.3969/j.issn.1674-4985.2013.27.013
10.3969/j.issn.1672-271X.2015.06.013
10.3321/j.issn:1007-7480.2008.05.003
10.55563/clinexprheumatol/dybvei
10.1136/rmdopen-2021-001867
ContentType Journal Article
Copyright The Author(s) 2022
2022. The Author(s).
Copyright_xml – notice: The Author(s) 2022
– notice: 2022. The Author(s).
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1007/s11926-022-01079-1
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1534-6307
EndPage 258
ExternalDocumentID PMC9307523
35829981
10_1007_s11926_022_01079_1
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: CAMS Innovation Fund for Medical Sciences (CIFMS)
  grantid: 2021-I2M-1-005
– fundername: ;
  grantid: 2021-I2M-1-005
GroupedDBID ---
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
203
29F
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
4.4
406
408
40D
40E
53G
5GY
5VS
6NX
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACREN
ACSNA
ACZOJ
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEGXH
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
AXYYD
B-.
BA0
BDATZ
BGNMA
BSONS
C1A
C6C
CAG
COF
CS3
CSCUP
CUW
DDRTE
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
ESBYG
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
H13
HF~
HG6
HMJXF
HRMNR
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
I~Z
J-C
JBSCW
JZLTJ
KOV
LLZTM
M4Y
MA-
N9A
NPVJJ
NQJWS
NU0
O9-
O9J
P9S
PF0
PT4
PT5
QOR
QOS
R89
R9I
RNI
ROL
RPX
RSV
RZK
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
YLTOR
Z7U
Z81
Z82
Z87
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c512t-b00a4d0e8e50acd54cf69a12c47d7e8b47cf0f440b3122793c8dd97f154173e23
IEDL.DBID C6C
ISSN 1523-3774
1534-6307
IngestDate Thu Aug 21 14:32:27 EDT 2025
Tue Aug 05 08:43:21 EDT 2025
Mon Jul 21 06:00:40 EDT 2025
Tue Jul 01 00:44:40 EDT 2025
Thu Apr 24 23:01:55 EDT 2025
Fri Feb 21 02:44:59 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Treatment
Enteropathic SpA
Chinese
Spondyloarthritis
HLA-B27
Epidemiology
Ankylosing spondylitis
Juvenile idiopathic arthritis
Psoriatic arthritis
Language English
License 2022. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c512t-b00a4d0e8e50acd54cf69a12c47d7e8b47cf0f440b3122793c8dd97f154173e23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0003-3560-2004
OpenAccessLink https://doi.org/10.1007/s11926-022-01079-1
PMID 35829981
PQID 2689055617
PQPubID 23479
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9307523
proquest_miscellaneous_2689055617
pubmed_primary_35829981
crossref_citationtrail_10_1007_s11926_022_01079_1
crossref_primary_10_1007_s11926_022_01079_1
springer_journals_10_1007_s11926_022_01079_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-08-01
PublicationDateYYYYMMDD 2022-08-01
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-01
  day: 01
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationTitle Current rheumatology reports
PublicationTitleAbbrev Curr Rheumatol Rep
PublicationTitleAlternate Curr Rheumatol Rep
PublicationYear 2022
Publisher Springer US
Publisher_xml – name: Springer US
References Bao, Huang, Khan, Fei, Wu, Han, Hsia (CR81) 2014; 53
Wu, Huang, Pan, Gu, Lu (CR60) 2007; 9
Li, Zhang, Wang, Shi (CR83) 2013; 23
Wu, Zhu, Wang, Zheng, Lu, Jia, Ding, Leng, Liu, Zhang (CR15) 2008; 29
Tang, Chen, Zheng, Wu, Chen, Zhu, Li (CR88) 2021; 41
Song, Deng, Xie, Li, Zhang (CR51) 2021; 8
Yi, Wang, Wang, Tang, Peng, Qing, Zhou (CR69) 2018; 13
Tan, Fong, Kwan, Leung (CR103) 2020; 40
Tam, Leung, Li (CR102) 2009; 48
Wang, Jin, Zhang (CR70) 2016; 23
Zeng, Chen, Zeng, Hou, He, Huang, Wu, Chen (CR18) 2008; 24
Huang, Zhang, Zheng, Xu, Li, Wu, Chen, Zhao, Zhang (CR80) 2011; 50
Stolwijk, van Tubergen, Castillo-Ortiz, Boonen (CR73) 2015; 74
Zhang, Wang, Peng, Su, Zeng, Li, Wu, Xu, Yang, Wu, Zhao, Duan, Li, Zhu, Fan (CR31) 2020; 7
Lou, Chen, Wu, Zhang (CR61) 2017; 6
Lockard (CR4) 2013; 11
Liu, Li, Hu, Zhou, Chen, Ning, Yao (CR104) 2010; 30
Reveille, Maganti (CR67) 2009; 649
Cai, Zhang, Zheng, Zhang, Patekar (CR108) 2021; 134
Zhang, Wang, Li, Luo, Zhang, Sha, Zhang (CR55) 2019; 8
Chen, Yang, Zhang, Fan, Xiao, Qian, Chang, Zuo, Zheng, Liang, Zhang, Sun, Yang, Zhang (CR53) 2019; 311
Ng, Liao, Yu, Chan, Zhao, Gu (CR26) 2007; 37
CR41
van der Heijde, Ramiro, Landewé, Baraliakos, Van den Bosch, Sepriano, Regel, Ciurea, Dagfinrud, Dougados, van Gaalen, Géher, van der Horst-Bruinsma, Inman, Jongkees, Kiltz, Kvien, Machado, Marzo-Ortega, Molto, Navarro-Compàn, Ozgocmen, Pimentel-Santos, Reveille, Rudwaleit, Sieper, Sampaio-Barros, Wiek, Braun (CR6) 2017; 76
Li, Li, Ji, Gu (CR39) 2018; 26
Mou, Zhang, Li, Lin, Liao, Wei, Gu (CR49) 2015; 2015
Taurog, Chhabra, Colbert (CR7) 2016; 374
Accortt, Bonafede, Collier, Iles, Curtis (CR86) 2016; 68
Sun, Cui, Dong, Sun, Meng (CR79) 2018; 24
Lai, Wu, Guo, Wang, Zhou (CR50) 2004; 8
Ossum, Palm, Lunder, Cvancarova, Banitalebi, Negård, Høie, Henriksen, Moum, Høivik (CR112) 2018; 12
Liu, Yang, Li, Cai, Liao, Li, Wu, Wang (CR43) 2016; 39
Li, Li, Cui, Ma, Cai, Guo, Han (CR76) 2005; 16
Ye, Zhuang, Wang, Li, Zhang (CR22) 2006; 10
Su, Cui, Yang, Shi, Jin, Shu, Li, Zeng, Wu, Gao (CR58) 2021; 39
Brophy, Mackay, Al-Saidi, Taylor, Calin (CR63) 2002; 29
Guan, Wang, Zhu, Xiao, Zhao, Li, Shi (CR45) 2014; 44
Wu, Wang, Zhang, Xu (CR8) 2021; 12
Sun (CR71) 2017
Yan, Zhang, Han, Huang, Zhang, Fang, Zheng, Yawalkar, Chang, Zhang, Jin, Qian, Li, Wu, Xu, Zhang, Xu (CR107) 2019; 155
Zeng, Gong, Zhang, Chen, Chen, Lin, Peng, Hou, Zhong, Liang, Huang, Wang, Lai, Li, Zeng (CR24) 2015; 10
Liu, Ma, Yue, Liu, Jiang, Xu (CR38) 2020; 34
Luo, Zhao, Zhang, Leng (CR40) 2019; 47
CR66
Nygaard, Ljungdalh, Iachina, Nikolov, Schiøttz-Christensen (CR12) 2020; 49
van der Heijde, Sieper, Maksymowych, Dougados, Burgos-Vargas, Landewé, Rudwaleit, Braun (CR85) 2011; 70
Wang, Yuan, Li, Tian, Li, Su, Zhang (CR16) 2013; 22
Palm, Moum, Ongre, Gran (CR111) 2002; 29
Ritchlin, Colbert, Gladman (CR100) 2017; 376
Arévalo, Gratacós Masmitjà, Moreno, Calvet, Orellana, Ruiz, Castro, Carreto, Larrosa, Collantes, Font (CR34) 2018; 20
Wang, Zhang, Ma, Hou, Liu (CR21) 2011; 32
Chen, Chen, Liao, Lin, Chen, Chen, Chien, Chou (CR48) 2012; 39
Zeng, Chen, Darmawan, Xiao, Chen, Wigley, Le Chen, Zhang (CR30) 2008; 10
Ji, Zhu, Yang, Wen, Gao, Pei, Sun, Du, Wang (CR62) 2016; 20
Zhang, Bai, Cao, Ji, Wang, Yang, Yang (CR109) 2021; 12
Ma, Ji, Hu, Wang, Zhu, Zhang, Huang (CR110) 2020; 59
Feldtkeller, Khan, van der Heijde, van der Linden, Braun (CR59) 2003; 23
Leung, Ho, Li, Li, Kwok, Wong, Li, Zhu, Kun, Tam (CR105) 2014; 15
Nikiphorou, van der Heijde, Norton, Landewé, Molto, Dougados, Van den Bosch, Ramiro (CR91) 2018; 77
Zhang, Wan, Liu, Dai, Zou, Qian, Ding, Xu, Ji, He, Zhu, Yang, Ye, Jiang, Tang, Tong, He, Zhao, Li, Ma, Zhou, Mei, Chen, Yuan, Zhang, Wang, Yang, Jin, Gao, Zhou, Reveille, Zou, Wang (CR56) 2018; 37
Zhao, Huang, Huang, Pan, Zeng, Luo, Liang, Yang, Liu (CR25) 2020; 40
Li, Meng, Gu, Chen, Wang (CR64) 2021; 36
Huang, Gu, Zhu, Bao, Xu, Xu, Wu, Wang, Shi, Andhivarothai, Anderson, Pangan (CR82) 2014; 73
Han, Ding, Zheng, Zhang, Zhu (CR65) 2021; 15
Huang, Sun, Wan, Wu, Dong, Zhang, Kim, Sengupta, Senolt, Wang, Qiu, Porter, Haemmerle (CR89) 2020; 133
Mou, Wu, Gu, Liao, Lin, Wei, Huang, Li (CR46) 2010; 75
Zhou, Zhao, Xiao, Chen, Guo, Wang, Chen, Zhao, Zhang, Jiao, Ju, Yang, Fei, Wang, Shen, Li, Wang, Lu, Yang, Liu, Li, Peng, Zheng, Zhang, Zhou, Wu, Yang, Su, Shi, Wu, Zhang, Zhang, Jia, Liu, Jie, Zhang (CR57) 2020; 107
Zeboulon, Dougados, Gossec (CR74) 2008; 67
Sampaio-Barros, van der Horst-Bruinsma (CR87) 2014; 28
Qian, Xu, He, Ji, Zhang, Ding, Dai, Zou, Zhu, Yang, Ye, Jiang, Tang, Tong, He, Zhao, Li, Ma, Zhou, Yuan, Zhang, Jin, Zhou, Reveille, Zou, Wang (CR32) 2017; 36
Wen, Jiang, Liu, Huang, Chen, Chen, Pan, Gu (CR77) 2019; 99
Lai, Kuo, Liao (CR114) 2021; 80
Stolwijk, van Onna, Boonen, van Tubergen (CR28) 2016; 68
Stone, Warren, Bruckel, Cooper, Cortinovis, Inman (CR94) 2005; 53
Liao, Lin, Chang, Chen, Liang, Chen, Su, Tsai, Chou (CR52) 2008; 35
Kim, Kim (CR33) 2010; 77
Qi, Li, Lin, Liao, Wei, Cao, Rong, Hu, Yang, Zhang, Lv, Huang, Pan, Wu, Jin, Li, Gu (CR42) 2013; 82
de Winter, van Mens, van der Heijde, Landewé, Baeten (CR72) 2016; 18
Leung, Tam, Ho, Lau, Li, Zhu, Kun, Li (CR106) 2010; 49
Reveille, Weisman (CR27) 2013; 345
Su, Li, He, Zhao, Wan, Liu, Xu, Xu, Liu, Jiang, Wu, Zuo, Huang, Liu, Li, Zhang, Liu, Dong, Li, Chen, Li, He, Lu, Huang, Tao, Wang, Zhang, Wei, Li, Zeng (CR84) 2020; 34
Sieper, Poddubnyy (CR68) 2017; 390
Bohn, Cooney, Deodhar, Curtis, Golembesky (CR13) 2018; 36
Song, Deng, Xie, Li, Zhang (CR101) 2021; 8
Khan (CR37) 2017; 19
Song, Hu, Wu, Yang, Gu (CR54) 2011; 42
CR17
Dong, Zang, Zhang, Zheng (CR20) 2006; 6
Chen, Wu, Wu, Luo, Zhong, Chen (CR75) 2021; 25
Bakland, Nossent, Gran (CR14) 2005; 53
CR10
CR98
Man, Ji, Wang, Ma, Hu, Zhu, Zhang, Huang (CR92) 2020; 26
CR93
Benegas, Muñoz-Gomariz, Font, Burgos-Vargas, Chaves, Palleiro, Maldonado Cocco, Gutiérrez, Sáenz, Steckmen, Rillo, Mulero, Sampaio-Barros, Barcelos, Vander Cruyssen, Vazquez-Mellado, Collantes (CR35) 2012; 39
Zhang, Li, Deng, Huang (CR3) 2011; 23
Karamanlioğlu, Aktas, Ozkan, Kaysin, Girgin (CR78) 2016; 36
Bao, Chen, Bao (CR99) 2014; 95
Khan (CR29) 1995; 7
Liao, Pan, Huang, Huang, Chi, Zhang, Lin, Wu, He, Wu, Xie, Huang, Wei, Li, Wu, Yu, Gu (CR23) 2009; 38
Brown, Xu, Li (CR1) 2020; 59
Wei, Baeten, Sieper, Deodhar, Bhosekar, Martin, Porter (CR90) 2017; 20
Wang, Tsou, Chiou, Wang, Zhang, Wei (CR113) 2020; 11
Lin, Liang, Chen, Lin (CR96) 2009; 72
Wright, Crowson, Michet, Matteson (CR11) 2015; 67
Chen, Du, Lin, Chen, Lin, Xu, Xie (CR19) 2005; 9
Riley, Ansell, Bywaters (CR95) 1971; 30
Zhang, Huang (CR47) 2001; 5
Dougados, Baeten (CR2) 2011; 377
Feltkamp, Mardjuadi, Huang, Chou (CR5) 2001; 13
Wang, Kim, Li, Cortes, Kim, Bang, Leo, Brown, Xu (CR44) 2020; 22
Su, Cui, Yang, Shi, Jin, Shu, Li, Zeng, Wu, Gao (CR9) 2019; 14
Liu, Song, Man, Yan, Li, Dong, Gao (CR97) 2020; 19
Gladman, Rahman, Cook, Shen, Zummer, Thomson, Nair, Rohekar, Ayearst, Inman, Maksymowych (CR36) 2011; 38
G Wang (1079_CR44) 2020; 22
YJ Lou (1079_CR61) 2017; 6
ZB Wu (1079_CR15) 2008; 29
1079_CR41
YY Leung (1079_CR106) 2010; 49
L Wang (1079_CR21) 2011; 32
YQ Wu (1079_CR60) 2007; 9
LS Tam (1079_CR102) 2009; 48
S Zhang (1079_CR3) 2011; 23
C Stolwijk (1079_CR73) 2015; 74
O Palm (1079_CR111) 2002; 29
M Dougados (1079_CR2) 2011; 377
MA Brown (1079_CR1) 2020; 59
N Zeboulon (1079_CR74) 2008; 67
MA Khan (1079_CR29) 1995; 7
K Yan (1079_CR107) 2019; 155
HT Li (1079_CR64) 2021; 36
Y Mou (1079_CR49) 2015; 2015
F Huang (1079_CR80) 2011; 50
C Bao (1079_CR81) 2014; 53
DŞ Karamanlioğlu (1079_CR78) 2016; 36
M Benegas (1079_CR35) 2012; 39
H Li (1079_CR39) 2018; 26
Y Mou (1079_CR46) 2010; 75
A Nygaard (1079_CR12) 2020; 49
R Chen (1079_CR19) 2005; 9
Q Han (1079_CR65) 2021; 15
JD Reveille (1079_CR27) 2013; 345
MA Khan (1079_CR37) 2017; 19
NA Accortt (1079_CR86) 2016; 68
YP Ma (1079_CR110) 2020; 59
SY Zeng (1079_CR24) 2015; 10
C Stolwijk (1079_CR28) 2016; 68
ZH Li (1079_CR83) 2013; 23
DD Gladman (1079_CR36) 2011; 38
JC Wei (1079_CR90) 2017; 20
H Song (1079_CR54) 2011; 42
Q Qian (1079_CR32) 2017; 36
1079_CR93
JM Lai (1079_CR50) 2004; 8
CA Lockard (1079_CR4) 2013; 11
W Liu (1079_CR97) 2020; 19
1079_CR10
1079_CR98
WY Zhang (1079_CR55) 2019; 8
1079_CR17
X Wu (1079_CR8) 2021; 12
ZZ Ye (1079_CR22) 2006; 10
SW Lai (1079_CR114) 2021; 80
JSQ Tan (1079_CR103) 2020; 40
JD Reveille (1079_CR67) 2009; 649
S Wang (1079_CR113) 2020; 11
YY Leung (1079_CR105) 2014; 15
JM Su (1079_CR58) 2021; 39
J Su (1079_CR9) 2019; 14
CT Ritchlin (1079_CR100) 2017; 376
X Liu (1079_CR104) 2010; 30
YY Sun (1079_CR79) 2018; 24
F Huang (1079_CR89) 2020; 133
KA Wright (1079_CR11) 2015; 67
L Cai (1079_CR108) 2021; 134
M Arévalo (1079_CR34) 2018; 20
YQ Wen (1079_CR77) 2019; 99
HT Liao (1079_CR52) 2008; 35
MJ Riley (1079_CR95) 1971; 30
WW Wang (1079_CR70) 2016; 23
J Chen (1079_CR53) 2019; 311
F Huang (1079_CR82) 2014; 73
S Brophy (1079_CR63) 2002; 29
HY Dong (1079_CR20) 2006; 6
J Zhao (1079_CR25) 2020; 40
J Qi (1079_CR42) 2013; 82
M Zhang (1079_CR109) 2021; 12
TJ Kim (1079_CR33) 2010; 77
E Nikiphorou (1079_CR91) 2018; 77
F Luo (1079_CR40) 2019; 47
Z Song (1079_CR101) 2021; 8
G Bakland (1079_CR14) 2005; 53
E Feldtkeller (1079_CR59) 2003; 23
AM Ossum (1079_CR112) 2018; 12
M Stone (1079_CR94) 2005; 53
D van der Heijde (1079_CR85) 2011; 70
D van der Heijde (1079_CR6) 2017; 76
C Zhou (1079_CR57) 2020; 107
1079_CR66
YC Lin (1079_CR96) 2009; 72
Q Liu (1079_CR38) 2020; 34
H Zhang (1079_CR56) 2018; 37
J Sieper (1079_CR68) 2017; 390
S Man (1079_CR92) 2020; 26
L Sun (1079_CR71) 2017
GF Chen (1079_CR75) 2021; 25
XJ Ji (1079_CR62) 2016; 20
SC Ng (1079_CR26) 2007; 37
JL Zhang (1079_CR47) 2001; 5
QY Zeng (1079_CR30) 2008; 10
X Liu (1079_CR43) 2016; 39
M Guan (1079_CR45) 2014; 44
HA Chen (1079_CR48) 2012; 39
Z Song (1079_CR51) 2021; 8
T Yi (1079_CR69) 2018; 13
J Bao (1079_CR99) 2014; 95
TE Feltkamp (1079_CR5) 2001; 13
S Zhang (1079_CR31) 2020; 7
JJ de Winter (1079_CR72) 2016; 18
C Tang (1079_CR88) 2021; 41
XG Zeng (1079_CR18) 2008; 24
JD Taurog (1079_CR7) 2016; 374
L Wang (1079_CR16) 2013; 22
YQ Li (1079_CR76) 2005; 16
PD Sampaio-Barros (1079_CR87) 2014; 28
R Bohn (1079_CR13) 2018; 36
ZT Liao (1079_CR23) 2009; 38
J Su (1079_CR84) 2020; 34
References_xml – volume: 76
  start-page: 978
  year: 2017
  end-page: 991
  ident: CR6
  article-title: 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2016-210770
– volume: 9
  start-page: 67
  year: 2007
  end-page: 68
  ident: CR60
  article-title: Clinical analysis of ankylosing spondylitis and low back pain in 782 cases
  publication-title: J Chin Physician
  doi: 10.3760/cma.j.issn.1008-1372.2007.01.025
– volume: 29
  start-page: 511
  year: 2002
  end-page: 515
  ident: CR111
  article-title: Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study)
  publication-title: J Rheumatol
– volume: 59
  start-page: iv58
  year: 2020
  end-page: 66
  ident: CR1
  article-title: Genetics and the axial spondyloarthritis spectrum
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keaa464
– volume: 23
  start-page: 334
  year: 2011
  end-page: 338
  ident: CR3
  article-title: Similarities and differences between spondyloarthritis in Asia and other parts of the world
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/BOR.0b013e32834640a9
– volume: 6
  start-page: 262
  year: 2006
  end-page: 5
  ident: CR20
  article-title: Epidemiological study of seronegative spondyloarthropathies in Taiyuan
  publication-title: Chin Remedies Clinics.
  doi: 10.3969/j.issn.1671-2560.2006.04.007
– volume: 20
  start-page: 589
  year: 2017
  end-page: 596
  ident: CR90
  article-title: Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies
  publication-title: Int J Rheum Dis
  doi: 10.1111/1756-185x.13094
– volume: 6
  start-page: 5
  year: 2017
  end-page: 10
  ident: CR61
  article-title: Establishment of ankylosing spondylitis database based on the combination of disease and syndrome and 379 cases of baseline data
  publication-title: Rheumatism and Arthritis
  doi: 10.3969/j.issn.2095-4174.2017.07.001
– volume: 23
  start-page: 186
  year: 2016
  end-page: 190
  ident: CR70
  article-title: Clinical analysis of ankylosing spondylitis complicated with uveitis
  publication-title: Chin J Clin Med
– volume: 24
  start-page: 30
  year: 2018
  end-page: 34
  ident: CR79
  article-title: Randomized, controlled trial: efficacy of ultrasound and exercise in patients with Ankylosing Spondylitis
  publication-title: Altern Ther Health Med
– volume: 8
  start-page: 1845
  year: 2021
  end-page: 1857
  ident: CR51
  article-title: Clinical characteristics of psoriatic arthritis in Chinese patients: a cross-sectional study
  publication-title: Rheumatol Ther
  doi: 10.1007/s40744-021-00384-y
– volume: 390
  start-page: 73
  year: 2017
  end-page: 84
  ident: CR68
  article-title: Axial spondyloarthritis
  publication-title: Lancet
  doi: 10.1016/s0140-6736(16)31591-4
– volume: 48
  start-page: 1473
  year: 2009
  end-page: 1477
  ident: CR102
  article-title: Psoriatic arthritis in Asia
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kep230
– volume: 36
  start-page: 500
  year: 2021
  end-page: 503
  ident: CR64
  article-title: Clinical characteristics of ankylosing spondylitis with hip involvement
  publication-title: Clin Focus
  doi: 10.3969/j.issn.1004-583X.2021.06.003
– volume: 15
  start-page: 284
  year: 2014
  ident: CR105
  article-title: Predictors of functional deterioration in Chinese patients with psoriatic arthritis: a longitudinal study
  publication-title: BMC Musculoskelet Disord
  doi: 10.1186/1471-2474-15-284
– volume: 59
  start-page: 189
  year: 2020
  end-page: 194
  ident: CR110
  article-title: Clinical characteristics of patients with ankylosing spondylitis and inflammatory bowel disease
  publication-title: Chin J Intern Med
  doi: 10.3760/cma.j.issn.0578-1426.2020.03.004
– volume: 40
  start-page: 859
  year: 2020
  end-page: 872
  ident: CR25
  article-title: Prevalence of ankylosing spondylitis in a Chinese population: a systematic review and meta-analysis
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-020-04537-0
– volume: 73
  start-page: 587
  year: 2014
  end-page: 594
  ident: CR82
  article-title: Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2012-202533
– volume: 9
  start-page: 148
  year: 2005
  end-page: 149
  ident: CR19
  article-title: Epidemiological study on spondyloarthropathy in 1982 workers and their relatives residing in Beijing urban district
  publication-title: China J Clin Rehabilt
  doi: 10.3321/j.issn:1673-8225.2005.39.003
– volume: 80
  start-page: e144
  year: 2021
  ident: CR114
  article-title: Incidence of inflammatory bowel disease in patients with ankylosing spondylitis
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2019-216362
– volume: 35
  start-page: 891
  year: 2008
  end-page: 895
  ident: CR52
  article-title: Human leukocyte antigen and clinical and demographic characteristics in psoriatic arthritis and psoriasis in Chinese patients
  publication-title: J Rheumatol
– volume: 34
  start-page: 381
  year: 2020
  end-page: 393
  ident: CR84
  article-title: Comparison of the efficacy and safety of adalimumab (humira) and the adalimumab biosimilar candidate (hs016) in chinese patients with active ankylosing spondylitis: a multicenter, randomized, double-blind, parallel, phase III clinical trial
  publication-title: BioDrugs
  doi: 10.1007/s40259-020-00408-z
– volume: 2015
  start-page: 594878
  year: 2015
  ident: CR49
  article-title: Clinical features in juvenile-onset Ankylosing Spondylitis patients carrying different B27 subtypes
  publication-title: Biomed Res Int
  doi: 10.1155/2015/594878
– volume: 42
  start-page: 53
  issue: 147–9
  year: 2011
  ident: CR54
  article-title: Comparative analysis of clinical features of patients from the south and north China with ankylosing spondylitis
  publication-title: New Med
  doi: 10.3969/g.issn.0253-9802.2011.03.003
– volume: 34
  start-page: 8
  issue: 271–3
  year: 2020
  ident: CR38
  article-title: Analysis of HLA-B27 genotype and clinical characteristics in patients with ankylosing spondylitis
  publication-title: J China-Jpn Friendsh Hosp
  doi: 10.3969/j.issn.1001-0025.2020.05.004
– volume: 50
  start-page: 1043
  year: 2011
  end-page: 1047
  ident: CR80
  article-title: A multicenter, double-blind, randomized, placebo-controlled clinical trial of etanercept treatment of Chinese patients with active ankylosing spondylitis
  publication-title: Chin J Intern Med
  doi: 10.3760/cma.j.issn.0578-1426.2011.12.013
– volume: 53
  start-page: 445
  year: 2005
  end-page: 451
  ident: CR94
  article-title: Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset Ankylosing Spondylitis
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21174
– volume: 16
  start-page: 584
  year: 2005
  end-page: 587
  ident: CR76
  article-title: CT features of sacroiliitis and its relationship with Gender, disease duration and onset age of juvenile ankylosing spondilytis
  publication-title: J Chin Clin Med Imaging
  doi: 10.3969/j.issn.1008-1062.2005.10.015
– volume: 82
  start-page: 380
  year: 2013
  end-page: 386
  ident: CR42
  article-title: Higher risk of uveitis and dactylitis and older age of onset among ankylosing spondylitis patients with HLA-B*2705 than patients with HLA-B*2704 in the Chinese population
  publication-title: Tissue Antigens
  doi: 10.1111/tan.12254
– volume: 11
  start-page: 578732
  year: 2020
  ident: CR113
  article-title: Increased risk of inflammatory bowel disease among patients with ankylosing spondylitis: a 13-year population-based cohort study
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.578732
– volume: 68
  start-page: 67
  year: 2016
  end-page: 76
  ident: CR86
  article-title: Risk of subsequent infection among patients receiving tumor necrosis factor inhibitors and other disease-modifying antirheumatic drugs
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.39416
– ident: CR66
– volume: 23
  start-page: 61
  year: 2003
  end-page: 6
  ident: CR59
  article-title: Age at disease onset and diagnosis delay in HLA-B27 negative vs positive patients with ankylosing spondylitis
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-002-0237-4
– volume: 20
  start-page: 669
  year: 2016
  end-page: 674
  ident: CR62
  article-title: Prospective study of ankylosing spondylitis with smart management system for spondyloarthritis:baseline characteristics of 449 consecutive patients
  publication-title: Chin J Rheumatol
  doi: 10.3760/cma.j.issn.1007-7480.2016.10.005
– volume: 24
  start-page: 1432
  year: 2008
  end-page: 1434
  ident: CR18
  article-title: Epidemiological survey of common rheumatic in Guangxi Nanning Zhuang population
  publication-title: J Pract Med
  doi: 10.3969/j.issn.1006-5725.2008.08.074
– volume: 649
  start-page: 159
  year: 2009
  end-page: 176
  ident: CR67
  article-title: Subtypes of HLA-B27: history and implications in the pathogenesis of ankylosing spondylitis
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-1-4419-0298-6_12
– volume: 36
  start-page: 653
  year: 2016
  end-page: 661
  ident: CR78
  article-title: Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a double-blind, randomized, placebo-controlled trial
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-016-3441-3
– ident: CR10
– volume: 74
  start-page: 65
  year: 2015
  end-page: 73
  ident: CR73
  article-title: Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-203582
– volume: 67
  start-page: 836
  year: 2015
  end-page: 841
  ident: CR11
  article-title: Time trends in incidence, clinical features, and cardiovascular disease in Ankylosing Spondylitis over three decades: a population-based study
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.22512
– volume: 75
  start-page: 56
  year: 2010
  end-page: 60
  ident: CR46
  article-title: HLA-B27 polymorphism in patients with juvenile and adult-onset Ankylosing Spondylitis in Southern China
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.2009.01406.x
– volume: 53
  start-page: 1654
  year: 2014
  end-page: 1663
  ident: CR81
  article-title: Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keu132
– volume: 23
  start-page: 497
  year: 2013
  end-page: 506
  ident: CR83
  article-title: Etanercept in the treatment of Ankylosing Spondylitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials, and the comparison of the Caucasian and Chinese population
  publication-title: Eur J Orthop Surg Traumatol
  doi: 10.1007/s00590-012-1035-7
– volume: 15
  start-page: 154
  year: 2021
  end-page: 158
  ident: CR65
  article-title: Related factors of hip joint lesions in ankylosing spondylitis
  publication-title: Chin J Allergy & Clin Immunol
  doi: 10.3969/j.issn.1673-8705.2021.02.005
– volume: 28
  start-page: 747
  year: 2014
  end-page: 763
  ident: CR87
  article-title: Adverse effects of TNF inhibitors in SpA: are they different from RA?
  publication-title: Best Pract Res Clin Rheumatol
  doi: 10.1016/j.berh.2014.10.001
– volume: 39
  start-page: 73
  year: 2021
  end-page: 78
  ident: CR58
  article-title: Ideal physical activity in association with incident Ankylosing Spondylitis: a community-based, prospective cohort study
  publication-title: Clin Exp Rheumatol
  doi: 10.55563/clinexprheumatol/a6bvty
– volume: 10
  start-page: e0138492
  year: 2015
  ident: CR24
  article-title: Changes in the prevalence of rheumatic diseases in Shantou, China, in the past three decades: a COPCORD study
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0138492
– volume: 377
  start-page: 2127
  year: 2011
  end-page: 2137
  ident: CR2
  publication-title: Spondyloarthritis Lancet
  doi: 10.1016/s0140-6736(11)60071-8
– volume: 10
  start-page: 159
  year: 2006
  end-page: 161
  ident: CR22
  article-title: Epidemiological survey on prevalence of ankylosing spondylitis in 5922 Shenzhen inhabitants
  publication-title: China J Clin Rehabilt
  doi: 10.3321/j.issn:1673-8225.2006.28.008
– volume: 345
  start-page: 431
  year: 2013
  end-page: 436
  ident: CR27
  article-title: The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States
  publication-title: Am J Med Sci
  doi: 10.1097/maj.0b013e318294457f
– volume: 30
  start-page: 138
  year: 1971
  end-page: 148
  ident: CR95
  article-title: Radiological manifestations of ankylosing spondylitis according to age at onset
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.30.2.138
– volume: 67
  start-page: 955
  year: 2008
  end-page: 959
  ident: CR74
  article-title: Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2007.075754
– volume: 30
  start-page: 1305
  year: 2010
  end-page: 1309
  ident: CR104
  article-title: High frequencies of HLA-B27 in Chinese patients with suspected of ankylosing spondylitis
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-009-1148-4
– volume: 37
  start-page: 1605
  year: 2018
  end-page: 1616
  ident: CR56
  article-title: Smoking quantity determines disease activity and function in Chinese patients with Ankylosing Spondylitis
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-018-4016-3
– volume: 77
  start-page: 405
  year: 2018
  end-page: 411
  ident: CR91
  article-title: Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2017-212457
– volume: 13
  start-page: 285
  year: 2001
  end-page: 290
  ident: CR5
  article-title: Spondyloarthropathies in eastern Asia
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/00002281-200107000-00007
– volume: 72
  start-page: 573
  year: 2009
  end-page: 580
  ident: CR96
  article-title: Differences between juvenile-onset ankylosing spondylitis and adult-onset ankylosing spondylitis
  publication-title: J Chin Med Assoc
  doi: 10.1016/s1726-4901(09)70432-0
– volume: 70
  start-page: 905
  year: 2011
  end-page: 908
  ident: CR85
  article-title: 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2011.151563
– volume: 47
  start-page: 3171
  year: 2019
  end-page: 3178
  ident: CR40
  article-title: Comparison of HLA-B*27 subtypes between Chinese patients with ankylosing spondylitis and non-ankylosing spondylitis carriers
  publication-title: J Int Med Res
  doi: 10.1177/0300060519853929
– ident: CR41
– volume: 14
  start-page: e0211946
  year: 2019
  ident: CR9
  article-title: Baseline high-sensitivity C-reactive protein predicts the risk of incident ankylosing spondylitis: results of a community-based prospective study
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0211946
– volume: 19
  start-page: 1147
  year: 2020
  end-page: 51
  ident: CR97
  article-title: Clinical characteristics of juvenile-onset ankylosing spondilytis
  publication-title: Chin J Gen Pract.
  doi: 10.3760/cma.j.cn114798-20200622-00742
– volume: 99
  start-page: 812
  year: 2019
  end-page: 817
  ident: CR77
  article-title: Gender difference in clinical manifestations and comorbidities in the patients with spondyloarthritis
  publication-title: Natl Med J China
  doi: 10.3760/cma.j.issn.0376-2491.2019.11.003
– volume: 40
  start-page: 1825
  year: 2020
  end-page: 1834
  ident: CR103
  article-title: Prevalence and variables associated with fatigue in psoriatic arthritis: a cross-sectional study
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-020-04678-2
– ident: CR93
– volume: 26
  start-page: e921055
  year: 2020
  ident: CR92
  article-title: Add-on effects of conventional synthetic disease-modifying anti-rheumatic drugs in ankylosing spondylitis: data from a Real-World Registered study in China
  publication-title: Med Sci Monit
  doi: 10.12659/MSM.921055
– volume: 95
  start-page: 108
  year: 2014
  end-page: 111
  ident: CR99
  article-title: Prevalence and risk factors of low bone mineral density in juvenile onset ankylosing spondylitis
  publication-title: Calcif Tissue Int
  doi: 10.1007/s00223-014-9867-2
– volume: 107
  start-page: 102360
  year: 2020
  ident: CR57
  article-title: Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2019.102360
– volume: 26
  start-page: 65
  year: 2018
  end-page: 69
  ident: CR39
  article-title: Ankylosing Spondylitis patients with HLA-B*2704 have more uveitis than patients with HLA-B*2705 in a North Chinese population
  publication-title: Ocul Immunol Inflamm
  doi: 10.1080/09273948.2016.1188967
– volume: 39
  start-page: 1013
  year: 2012
  end-page: 1018
  ident: CR48
  article-title: Clinical, functional, and radiographic differences among juvenile-onset, adult-onset, and late-onset Ankylosing Spondylitis
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.111031
– volume: 12
  start-page: 96
  year: 2018
  end-page: 104
  ident: CR112
  article-title: Ankylosing spondylitis and axial spondyloarthritis in patients with long-term inflammatory bowel disease: results from 20 years of follow-up in the IBSEN Study
  publication-title: J Crohns Colitis
  doi: 10.1093/ecco-jcc/jjx126
– volume: 376
  start-page: 957
  year: 2017
  end-page: 970
  ident: CR100
  article-title: Psoriatic arthritis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1505557
– volume: 5
  start-page: 113
  year: 2001
  end-page: 116
  ident: CR47
  article-title: Clinical Characters of juvenile onset spondyloarthropathies
  publication-title: China J Rheumatol
  doi: 10.3760/j:issn:1007-7480.2001.02.011
– volume: 133
  start-page: 2521
  year: 2020
  end-page: 2531
  ident: CR89
  article-title: Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5
  publication-title: Chin Med J (Engl)
  doi: 10.1097/CM9.0000000000001099
– volume: 311
  start-page: 277
  year: 2019
  end-page: 285
  ident: CR53
  article-title: HLA-A*01:01 in MHC is associated with psoriatic arthritis in Chinese Han population
  publication-title: Arch Dermatol Res
  doi: 10.1007/s00403-019-01902-3
– volume: 44
  start-page: 601
  year: 2014
  end-page: 605
  ident: CR45
  article-title: Comparison in clinical features and life impact between juvenile-onset and adult-onset ankylosing spondylitis
  publication-title: Turk J Med Sci
  doi: 10.3906/sag-1306-64
– volume: 12
  start-page: 677957
  year: 2021
  ident: CR109
  article-title: The influence of corticosteroids, immunosuppressants and biologics on patients with inflammatory bowel diseases, psoriasis and rheumatic diseases in the era of COVID-19: a review of current evidence
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.677957
– volume: 374
  start-page: 2563
  year: 2016
  end-page: 2574
  ident: CR7
  article-title: Ankylosing Spondylitis and axial spondyloarthritis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1406182
– volume: 19
  start-page: 9
  year: 2017
  ident: CR37
  article-title: An Update on the genetic polymorphism of HLA-B*27 with 213 alleles encompassing 160 subtypes (and still counting)
  publication-title: Curr Rheumatol Rep
  doi: 10.1007/s11926-017-0640-1
– volume: 53
  start-page: 850
  year: 2005
  end-page: 855
  ident: CR14
  article-title: Incidence and prevalence of ankylosing spondylitis in Northern Norway
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21577
– volume: 37
  start-page: 39
  year: 2007
  end-page: 47
  ident: CR26
  article-title: Epidemiology of spondyloarthritis in the People’s Republic of China: review of the literature and commentary
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2007.01.003
– volume: 25
  start-page: 450
  year: 2021
  end-page: 454
  ident: CR75
  article-title: Risk factors of uveitis in ankylosing spondylitis
  publication-title: Chin J Rheumatol
  doi: 10.3760/cma.j.c141217-20201127-00454
– volume: 49
  start-page: 112
  year: 2010
  end-page: 115
  ident: CR106
  article-title: Evaluation of the CASPAR criteria for psoriatic arthritis in the Chinese population
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kep348
– volume: 77
  start-page: 235
  year: 2010
  end-page: 240
  ident: CR33
  article-title: Clinical spectrum of ankylosing spondylitis in Korea
  publication-title: Joint Bone Spine
  doi: 10.1016/j.jbspin.2009.11.015
– volume: 39
  start-page: 10
  year: 2016
  end-page: 15
  ident: CR43
  article-title: Association of HLA-DP/DQ and STAT4 polymorphisms with ankylosing spondylitis in Southwest China
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2016.06.033
– volume: 38
  start-page: 455
  year: 2009
  end-page: 459
  ident: CR23
  article-title: An epidemiological survey of low back pain and axial spondyloarthritis in a Chinese Han population
  publication-title: Scand J Rheumatol
  doi: 10.3109/03009740902978085
– volume: 155
  start-page: 327
  year: 2019
  end-page: 334
  ident: CR107
  article-title: Safety and efficacy of methotrexate for Chinese adults with psoriasis with and without psoriatic arthritis
  publication-title: JAMA Dermatol
  doi: 10.1001/jamadermatol.2018.5194
– volume: 39
  start-page: 2315
  year: 2012
  end-page: 2320
  ident: CR35
  article-title: Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.110687
– year: 2017
  ident: CR71
  publication-title: Risk factors of uveitis in ankylosing spondylitis
– volume: 10
  start-page: R17
  year: 2008
  ident: CR30
  article-title: Rheumatic diseases in China
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar2368
– volume: 41
  start-page: 633
  year: 2021
  end-page: 9
  ident: CR88
  article-title: Relapse of ankylosing spondylitis and its predictors after withdrawal of tumor necrosis factor-alpha inhibitors: a 52-week follow-up study
  publication-title: Nan Fang Yi Ke Da Xue Xue Bao
  doi: 10.12122/j.issn.1673-4254.2021.05.01
– volume: 134
  start-page: 2629
  year: 2021
  end-page: 2631
  ident: CR108
  article-title: Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
  publication-title: Chin Med J (Engl)
  doi: 10.1097/CM9.0000000000001710
– volume: 49
  start-page: 21
  year: 2020
  end-page: 27
  ident: CR12
  article-title: Incidence of ankylosing spondylitis and spondyloarthritis in 2000–2013: a nationwide Danish cohort study
  publication-title: Scand J Rheumatol
  doi: 10.1080/03009742.2019.1616324
– volume: 38
  start-page: 1343
  year: 2011
  end-page: 1348
  ident: CR36
  article-title: The spondyloarthritis research consortium of canada registry for spondyloarthritis
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.101102
– volume: 13
  start-page: 417
  year: 2018
  end-page: 421
  ident: CR69
  article-title: Epidemiological features and delayed diagnosis of 111 ankylosing spondylitis cases in northeastern Sichuan
  publication-title: J Chengdu Med Coll
  doi: 10.3969/j.issn.1674-2257.2018.04.008
– volume: 36
  start-page: 1561
  year: 2017
  end-page: 1568
  ident: CR32
  article-title: Clinical patterns and characteristics of ankylosing spondylitis in China
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-017-3660-3
– volume: 29
  start-page: 1696
  year: 2008
  end-page: 9
  ident: CR15
  article-title: Epidemiological investigation of rheumatoid arthritis and seronegative spondylarthritis in Chinese armed forces
  publication-title: J Fourth Mil Med Univ
  doi: 10.3321/j.issn:1000-2790.2008.18.017
– volume: 12
  start-page: 671682
  year: 2021
  ident: CR8
  article-title: Genetics of ankylosing spondylitis-focusing on the ethnic difference between East Asia and Europe
  publication-title: Front Genet
  doi: 10.3389/fgene.2021.671682
– volume: 8
  start-page: 617
  year: 2004
  end-page: 619
  ident: CR50
  article-title: The relationship between the Clinical Characters juvenile ankylosing spondilytis and substypes of HLA-B27
  publication-title: Chinese J Rheumatol
  doi: 10.3760/j:issn:1007-7480.2004.10.011
– volume: 29
  start-page: 1236
  year: 2002
  end-page: 1243
  ident: CR63
  article-title: The natural history of ankylosing spondylitis as defined by radiological progression
  publication-title: J Rheumatol
– ident: CR98
– volume: 68
  start-page: 1320
  year: 2016
  end-page: 1331
  ident: CR28
  article-title: Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.22831
– volume: 8
  start-page: 5
  issue: 39–42
  year: 2019
  ident: CR55
  article-title: Correlation of smoking with disease activity and imaging progression in male ankylosing spondylitis
  publication-title: Rheumatism and Arthritis
  doi: 10.3969/j.issn.2095-4174.2019.10.008
– volume: 22
  start-page: 74
  year: 2020
  ident: CR44
  article-title: MHC associations of ankylosing spondylitis in East Asians are complex and involve non-HLA-B27 HLA contributions
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-020-02148-5
– volume: 7
  start-page: 263
  year: 1995
  end-page: 269
  ident: CR29
  article-title: HLA-B27 and its subtypes in world populations
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/00002281-199507000-00001
– volume: 18
  start-page: 196
  year: 2016
  ident: CR72
  article-title: Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-016-1093-z
– volume: 32
  start-page: 19
  year: 2011
  end-page: 21
  ident: CR21
  article-title: Epidemiology investigation of spondyloarthropathy in Zaozhuang
  publication-title: J Med Forum
– volume: 36
  start-page: 263
  year: 2018
  end-page: 274
  ident: CR13
  article-title: Incidence and prevalence of axial spondyloarthritis: methodologic challenges and gaps in the literature
  publication-title: Clin Exp Rheumatol
– volume: 7
  start-page: 609562
  year: 2020
  ident: CR31
  article-title: Comparison of clinical features in HLA-B27 positive and negative patients with axial spondyloarthritis: results from a cohort of 4,131 patients
  publication-title: Front Med (Lausanne)
  doi: 10.3389/fmed.2020.609562
– ident: CR17
– volume: 8
  start-page: 1845
  year: 2021
  end-page: 1857
  ident: CR101
  article-title: Clinical characteristics of psoriatic arthritis in Chinese patients: a cross-sectional study
  publication-title: Rheumatol Ther
  doi: 10.1007/s40744-021-00384-y
– volume: 22
  start-page: 220
  year: 2013
  end-page: 221
  ident: CR16
  article-title: Epidemiological investigation of ankylosing spondylitis in recruits of one department of People’s Armed Police Forces
  publication-title: J Logistics Univ Cape (Medical Science)
  doi: 10.3969/j.issn.2095-3720.2013.03.022
– volume: 11
  start-page: 765
  year: 2013
  end-page: 781
  ident: CR4
  article-title: Chinese migration and settlement in Southeast Asia before 1850: making fields from the sea
  publication-title: History Compass
  doi: 10.1111/hic3.12079
– volume: 20
  start-page: 221
  year: 2018
  ident: CR34
  article-title: Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-018-1724-7
– volume: 36
  start-page: 263
  year: 2018
  ident: 1079_CR13
  publication-title: Clin Exp Rheumatol
– volume: 107
  start-page: 102360
  year: 2020
  ident: 1079_CR57
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2019.102360
– volume: 39
  start-page: 1013
  year: 2012
  ident: 1079_CR48
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.111031
– volume: 649
  start-page: 159
  year: 2009
  ident: 1079_CR67
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-1-4419-0298-6_12
– volume: 48
  start-page: 1473
  year: 2009
  ident: 1079_CR102
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kep230
– volume: 133
  start-page: 2521
  year: 2020
  ident: 1079_CR89
  publication-title: Chin Med J (Engl)
  doi: 10.1097/CM9.0000000000001099
– ident: 1079_CR93
  doi: 10.3969/j.issn.1674-4985.2013.27.013
– volume: 311
  start-page: 277
  year: 2019
  ident: 1079_CR53
  publication-title: Arch Dermatol Res
  doi: 10.1007/s00403-019-01902-3
– volume: 7
  start-page: 609562
  year: 2020
  ident: 1079_CR31
  publication-title: Front Med (Lausanne)
  doi: 10.3389/fmed.2020.609562
– volume: 53
  start-page: 445
  year: 2005
  ident: 1079_CR94
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21174
– volume: 34
  start-page: 381
  year: 2020
  ident: 1079_CR84
  publication-title: BioDrugs
  doi: 10.1007/s40259-020-00408-z
– volume: 99
  start-page: 812
  year: 2019
  ident: 1079_CR77
  publication-title: Natl Med J China
  doi: 10.3760/cma.j.issn.0376-2491.2019.11.003
– volume: 72
  start-page: 573
  year: 2009
  ident: 1079_CR96
  publication-title: J Chin Med Assoc
  doi: 10.1016/s1726-4901(09)70432-0
– ident: 1079_CR10
– volume: 12
  start-page: 96
  year: 2018
  ident: 1079_CR112
  publication-title: J Crohns Colitis
  doi: 10.1093/ecco-jcc/jjx126
– volume: 16
  start-page: 584
  year: 2005
  ident: 1079_CR76
  publication-title: J Chin Clin Med Imaging
  doi: 10.3969/j.issn.1008-1062.2005.10.015
– volume: 49
  start-page: 21
  year: 2020
  ident: 1079_CR12
  publication-title: Scand J Rheumatol
  doi: 10.1080/03009742.2019.1616324
– volume: 40
  start-page: 859
  year: 2020
  ident: 1079_CR25
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-020-04537-0
– volume: 37
  start-page: 39
  year: 2007
  ident: 1079_CR26
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2007.01.003
– volume: 82
  start-page: 380
  year: 2013
  ident: 1079_CR42
  publication-title: Tissue Antigens
  doi: 10.1111/tan.12254
– volume: 28
  start-page: 747
  year: 2014
  ident: 1079_CR87
  publication-title: Best Pract Res Clin Rheumatol
  doi: 10.1016/j.berh.2014.10.001
– volume: 40
  start-page: 1825
  year: 2020
  ident: 1079_CR103
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-020-04678-2
– volume: 42
  start-page: 53
  issue: 147–9
  year: 2011
  ident: 1079_CR54
  publication-title: New Med
  doi: 10.3969/g.issn.0253-9802.2011.03.003
– volume: 15
  start-page: 284
  year: 2014
  ident: 1079_CR105
  publication-title: BMC Musculoskelet Disord
  doi: 10.1186/1471-2474-15-284
– volume: 10
  start-page: 159
  year: 2006
  ident: 1079_CR22
  publication-title: China J Clin Rehabilt
  doi: 10.3321/j.issn:1673-8225.2006.28.008
– volume: 20
  start-page: 669
  year: 2016
  ident: 1079_CR62
  publication-title: Chin J Rheumatol
  doi: 10.3760/cma.j.issn.1007-7480.2016.10.005
– volume: 36
  start-page: 1561
  year: 2017
  ident: 1079_CR32
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-017-3660-3
– volume: 376
  start-page: 957
  year: 2017
  ident: 1079_CR100
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1505557
– volume: 155
  start-page: 327
  year: 2019
  ident: 1079_CR107
  publication-title: JAMA Dermatol
  doi: 10.1001/jamadermatol.2018.5194
– volume: 18
  start-page: 196
  year: 2016
  ident: 1079_CR72
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-016-1093-z
– volume: 390
  start-page: 73
  year: 2017
  ident: 1079_CR68
  publication-title: Lancet
  doi: 10.1016/s0140-6736(16)31591-4
– volume: 38
  start-page: 455
  year: 2009
  ident: 1079_CR23
  publication-title: Scand J Rheumatol
  doi: 10.3109/03009740902978085
– volume: 11
  start-page: 765
  year: 2013
  ident: 1079_CR4
  publication-title: History Compass
  doi: 10.1111/hic3.12079
– volume: 39
  start-page: 10
  year: 2016
  ident: 1079_CR43
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2016.06.033
– volume: 8
  start-page: 5
  issue: 39–42
  year: 2019
  ident: 1079_CR55
  publication-title: Rheumatism and Arthritis
  doi: 10.3969/j.issn.2095-4174.2019.10.008
– volume: 68
  start-page: 67
  year: 2016
  ident: 1079_CR86
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.39416
– volume: 53
  start-page: 850
  year: 2005
  ident: 1079_CR14
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21577
– ident: 1079_CR17
  doi: 10.3969/j.issn.1672-271X.2015.06.013
– volume: 12
  start-page: 677957
  year: 2021
  ident: 1079_CR109
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.677957
– volume: 59
  start-page: iv58
  year: 2020
  ident: 1079_CR1
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keaa464
– volume: 8
  start-page: 617
  year: 2004
  ident: 1079_CR50
  publication-title: Chinese J Rheumatol
  doi: 10.3760/j:issn:1007-7480.2004.10.011
– volume: 22
  start-page: 74
  year: 2020
  ident: 1079_CR44
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-020-02148-5
– volume: 14
  start-page: e0211946
  year: 2019
  ident: 1079_CR9
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0211946
– volume: 19
  start-page: 9
  year: 2017
  ident: 1079_CR37
  publication-title: Curr Rheumatol Rep
  doi: 10.1007/s11926-017-0640-1
– volume: 30
  start-page: 1305
  year: 2010
  ident: 1079_CR104
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-009-1148-4
– volume: 24
  start-page: 1432
  year: 2008
  ident: 1079_CR18
  publication-title: J Pract Med
  doi: 10.3969/j.issn.1006-5725.2008.08.074
– volume: 59
  start-page: 189
  year: 2020
  ident: 1079_CR110
  publication-title: Chin J Intern Med
  doi: 10.3760/cma.j.issn.0578-1426.2020.03.004
– volume: 134
  start-page: 2629
  year: 2021
  ident: 1079_CR108
  publication-title: Chin Med J (Engl)
  doi: 10.1097/CM9.0000000000001710
– volume: 5
  start-page: 113
  year: 2001
  ident: 1079_CR47
  publication-title: China J Rheumatol
  doi: 10.3760/j:issn:1007-7480.2001.02.011
– volume: 32
  start-page: 19
  year: 2011
  ident: 1079_CR21
  publication-title: J Med Forum
– volume: 9
  start-page: 67
  year: 2007
  ident: 1079_CR60
  publication-title: J Chin Physician
  doi: 10.3760/cma.j.issn.1008-1372.2007.01.025
– volume: 50
  start-page: 1043
  year: 2011
  ident: 1079_CR80
  publication-title: Chin J Intern Med
  doi: 10.3760/cma.j.issn.0578-1426.2011.12.013
– volume: 6
  start-page: 5
  year: 2017
  ident: 1079_CR61
  publication-title: Rheumatism and Arthritis
  doi: 10.3969/j.issn.2095-4174.2017.07.001
– volume: 377
  start-page: 2127
  year: 2011
  ident: 1079_CR2
  publication-title: Spondyloarthritis Lancet
  doi: 10.1016/s0140-6736(11)60071-8
– volume: 74
  start-page: 65
  year: 2015
  ident: 1079_CR73
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-203582
– volume: 29
  start-page: 1696
  year: 2008
  ident: 1079_CR15
  publication-title: J Fourth Mil Med Univ
  doi: 10.3321/j.issn:1000-2790.2008.18.017
– volume: 34
  start-page: 8
  issue: 271–3
  year: 2020
  ident: 1079_CR38
  publication-title: J China-Jpn Friendsh Hosp
  doi: 10.3969/j.issn.1001-0025.2020.05.004
– volume: 24
  start-page: 30
  year: 2018
  ident: 1079_CR79
  publication-title: Altern Ther Health Med
– volume: 76
  start-page: 978
  year: 2017
  ident: 1079_CR6
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2016-210770
– volume: 47
  start-page: 3171
  year: 2019
  ident: 1079_CR40
  publication-title: J Int Med Res
  doi: 10.1177/0300060519853929
– volume: 11
  start-page: 578732
  year: 2020
  ident: 1079_CR113
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.578732
– volume: 2015
  start-page: 594878
  year: 2015
  ident: 1079_CR49
  publication-title: Biomed Res Int
  doi: 10.1155/2015/594878
– volume: 8
  start-page: 1845
  year: 2021
  ident: 1079_CR101
  publication-title: Rheumatol Ther
  doi: 10.1007/s40744-021-00384-y
– volume: 75
  start-page: 56
  year: 2010
  ident: 1079_CR46
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.2009.01406.x
– volume: 70
  start-page: 905
  year: 2011
  ident: 1079_CR85
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2011.151563
– volume: 15
  start-page: 154
  year: 2021
  ident: 1079_CR65
  publication-title: Chin J Allergy & Clin Immunol
  doi: 10.3969/j.issn.1673-8705.2021.02.005
– ident: 1079_CR41
  doi: 10.3321/j.issn:1007-7480.2008.05.003
– ident: 1079_CR66
  doi: 10.55563/clinexprheumatol/dybvei
– volume: 23
  start-page: 186
  year: 2016
  ident: 1079_CR70
  publication-title: Chin J Clin Med
– volume: 36
  start-page: 500
  year: 2021
  ident: 1079_CR64
  publication-title: Clin Focus
  doi: 10.3969/j.issn.1004-583X.2021.06.003
– volume: 39
  start-page: 73
  year: 2021
  ident: 1079_CR58
  publication-title: Clin Exp Rheumatol
  doi: 10.55563/clinexprheumatol/a6bvty
– volume: 8
  start-page: 1845
  year: 2021
  ident: 1079_CR51
  publication-title: Rheumatol Ther
  doi: 10.1007/s40744-021-00384-y
– volume: 30
  start-page: 138
  year: 1971
  ident: 1079_CR95
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.30.2.138
– volume: 77
  start-page: 405
  year: 2018
  ident: 1079_CR91
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2017-212457
– volume: 80
  start-page: e144
  year: 2021
  ident: 1079_CR114
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2019-216362
– volume: 95
  start-page: 108
  year: 2014
  ident: 1079_CR99
  publication-title: Calcif Tissue Int
  doi: 10.1007/s00223-014-9867-2
– volume: 10
  start-page: e0138492
  year: 2015
  ident: 1079_CR24
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0138492
– volume: 22
  start-page: 220
  year: 2013
  ident: 1079_CR16
  publication-title: J Logistics Univ Cape (Medical Science)
  doi: 10.3969/j.issn.2095-3720.2013.03.022
– volume: 68
  start-page: 1320
  year: 2016
  ident: 1079_CR28
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.22831
– volume: 10
  start-page: R17
  year: 2008
  ident: 1079_CR30
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar2368
– volume: 53
  start-page: 1654
  year: 2014
  ident: 1079_CR81
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keu132
– volume: 67
  start-page: 836
  year: 2015
  ident: 1079_CR11
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.22512
– volume: 13
  start-page: 417
  year: 2018
  ident: 1079_CR69
  publication-title: J Chengdu Med Coll
  doi: 10.3969/j.issn.1674-2257.2018.04.008
– volume: 41
  start-page: 633
  year: 2021
  ident: 1079_CR88
  publication-title: Nan Fang Yi Ke Da Xue Xue Bao
  doi: 10.12122/j.issn.1673-4254.2021.05.01
– volume: 26
  start-page: e921055
  year: 2020
  ident: 1079_CR92
  publication-title: Med Sci Monit
  doi: 10.12659/MSM.921055
– volume: 26
  start-page: 65
  year: 2018
  ident: 1079_CR39
  publication-title: Ocul Immunol Inflamm
  doi: 10.1080/09273948.2016.1188967
– volume: 44
  start-page: 601
  year: 2014
  ident: 1079_CR45
  publication-title: Turk J Med Sci
  doi: 10.3906/sag-1306-64
– volume: 13
  start-page: 285
  year: 2001
  ident: 1079_CR5
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/00002281-200107000-00007
– volume: 23
  start-page: 497
  year: 2013
  ident: 1079_CR83
  publication-title: Eur J Orthop Surg Traumatol
  doi: 10.1007/s00590-012-1035-7
– volume: 29
  start-page: 511
  year: 2002
  ident: 1079_CR111
  publication-title: J Rheumatol
– volume: 35
  start-page: 891
  year: 2008
  ident: 1079_CR52
  publication-title: J Rheumatol
– volume: 19
  start-page: 1147
  year: 2020
  ident: 1079_CR97
  publication-title: Chin J Gen Pract.
  doi: 10.3760/cma.j.cn114798-20200622-00742
– volume: 29
  start-page: 1236
  year: 2002
  ident: 1079_CR63
  publication-title: J Rheumatol
– volume: 9
  start-page: 148
  year: 2005
  ident: 1079_CR19
  publication-title: China J Clin Rehabilt
  doi: 10.3321/j.issn:1673-8225.2005.39.003
– volume: 37
  start-page: 1605
  year: 2018
  ident: 1079_CR56
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-018-4016-3
– volume: 49
  start-page: 112
  year: 2010
  ident: 1079_CR106
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kep348
– volume: 374
  start-page: 2563
  year: 2016
  ident: 1079_CR7
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1406182
– volume: 25
  start-page: 450
  year: 2021
  ident: 1079_CR75
  publication-title: Chin J Rheumatol
  doi: 10.3760/cma.j.c141217-20201127-00454
– ident: 1079_CR98
  doi: 10.1136/rmdopen-2021-001867
– volume: 23
  start-page: 334
  year: 2011
  ident: 1079_CR3
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/BOR.0b013e32834640a9
– volume-title: Risk factors of uveitis in ankylosing spondylitis
  year: 2017
  ident: 1079_CR71
– volume: 12
  start-page: 671682
  year: 2021
  ident: 1079_CR8
  publication-title: Front Genet
  doi: 10.3389/fgene.2021.671682
– volume: 67
  start-page: 955
  year: 2008
  ident: 1079_CR74
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2007.075754
– volume: 39
  start-page: 2315
  year: 2012
  ident: 1079_CR35
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.110687
– volume: 6
  start-page: 262
  year: 2006
  ident: 1079_CR20
  publication-title: Chin Remedies Clinics.
  doi: 10.3969/j.issn.1671-2560.2006.04.007
– volume: 36
  start-page: 653
  year: 2016
  ident: 1079_CR78
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-016-3441-3
– volume: 20
  start-page: 589
  year: 2017
  ident: 1079_CR90
  publication-title: Int J Rheum Dis
  doi: 10.1111/1756-185x.13094
– volume: 38
  start-page: 1343
  year: 2011
  ident: 1079_CR36
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.101102
– volume: 73
  start-page: 587
  year: 2014
  ident: 1079_CR82
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2012-202533
– volume: 23
  start-page: 61
  year: 2003
  ident: 1079_CR59
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-002-0237-4
– volume: 77
  start-page: 235
  year: 2010
  ident: 1079_CR33
  publication-title: Joint Bone Spine
  doi: 10.1016/j.jbspin.2009.11.015
– volume: 20
  start-page: 221
  year: 2018
  ident: 1079_CR34
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-018-1724-7
– volume: 345
  start-page: 431
  year: 2013
  ident: 1079_CR27
  publication-title: Am J Med Sci
  doi: 10.1097/maj.0b013e318294457f
– volume: 7
  start-page: 263
  year: 1995
  ident: 1079_CR29
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/00002281-199507000-00001
SSID ssj0020083
Score 2.403374
SecondaryResourceType review_article
Snippet Purpose of Review This review aims to emphasize interesting and important new findings with a focus on the spectrum of spondyloarthritis (SpA) in China. Recent...
This review aims to emphasize interesting and important new findings with a focus on the spectrum of spondyloarthritis (SpA) in China. Over the past decade,...
This review aims to emphasize interesting and important new findings with a focus on the spectrum of spondyloarthritis (SpA) in China.PURPOSE OF REVIEWThis...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 247
SubjectTerms Arthritis, Psoriatic - drug therapy
Arthritis, Psoriatic - epidemiology
Arthritis, Psoriatic - genetics
Ethnicity
HLA-A Antigens - therapeutic use
HLA-B27 Antigen - genetics
Humans
Medicine
Medicine & Public Health
Rheumatology
Section Editors
Spondylarthritis - drug therapy
Spondylarthritis - epidemiology
Spondylarthritis - genetics
Spondylitis, Ankylosing - drug therapy
Spondylitis, Ankylosing - epidemiology
Spondylitis, Ankylosing - genetics
Spondyloarthritis (MA Khan and N Akkoc
Spondyloarthritis (MA Khan and N Akkoc, Section Editors
Topical Collection on Spondyloarthritis
Title Spectrum of Spondyloarthritis Among Chinese Populations
URI https://link.springer.com/article/10.1007/s11926-022-01079-1
https://www.ncbi.nlm.nih.gov/pubmed/35829981
https://www.proquest.com/docview/2689055617
https://pubmed.ncbi.nlm.nih.gov/PMC9307523
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEF6kBfEivo2PEsGbBrPJJps9ltJalIqghXoKyT6ooGkx7f93ZptG2orgJZfsLmFmNjPDzHwfIdcZj3PwDALSkihGCjPqiSjRXqLRmjBItYPCg6e4P2QPo2hUweTgLMxa_f6upBCCYJssNhD4XHiQ6TQjGnKkaejEnTq5wljCYqMGIVwazqoBmd_PWHVCG5HlZoPkWpXUOp_eHtmtoka3vVDzPtnSxQHZHlR18UPCkUZ-9jX_dCfGfZlOCgV5OBjF2EIWuW1kFHKRKluX2n2uObvKIzLsdV87fa-iRPAkeOYZ0uVkTPk60ZGfSRUxaWKR0UAyrrhOcsal8Q1jfh5SxAYMZaKU4AYCJcpDHYTHpFFMCn1K3CSmSueZNEGOqGFZxpU2EsIRZQQVhjmELmWUygovHGkrPtIfpGOUawpyTa1cU-qQm3rPdIGW8efqq6XoUzBqrFRkhZ7MyzSIE2GJO7lDThaqqM_D0V7IEWE3X1FSvQABs1ffFO9jC5wt4IcG9uGQ26U60-rGln985tn_lp-TncCaGjYJXpAGKF9fQuAyy1uk2b5_e-y2rOXCcxi0vwF_8eR6
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bS8MwFA6ioL6Id-e1gm9a6CVtmschjqnbENxgb6HNhQnaDbv9f8_J2o45GfjcJJSTk5zvkHO-j5C7lMUZRAYOaUkUo4SZ7_Io0W6i0ZsQpNpG4W4vbg_oyzAalk1hRVXtXj1J2pt60ewGYAQLZrGUwGPchZxnC8BAgr48CJp1moWowrKkBiEcH0bLVpm_11gORysYc7VU8td7qQ1DrX2yV-JHpznf8AOyofNDst0tX8iPCENB-en37MsZG-d9Ms4VZOTgHiNLXuQ0UVvIQdFsXWjnrVbvKo7JoPXUf2y7pTiCKyFGT1E4J6XK04mOvFSqiEoT89QPJGWK6SSjTBrPUOploY8sgaFMlOLMAGTyWaiD8IRs5uNcnxEniX2ls1SaIEP-sDRlShsJwEQZ7nNDG8SvbCRkyRyOAhafYsF5jHYVYFdh7Sr8Brmv50zmvBlrR99Wphfg3vhmkeZ6PCtEECfcSniyBjmdb0W9Hjb5QrYIs9nSJtUDkDp7-Uv-MbIU2hyuNvCPBnmotlOUZ7dY85vn_xt-Q3ba_W5HdJ57rxdkN7Buh6WDl2QTHEFfAZyZZtfWe38AhG_pFA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZS8NAEF5EQXwRb-sZwTcNZpNNNvtYqsWbghZ8W5I9qKBpse3_d2Zz1KoIPmezhNnZzDfMzPcRcprxJIfIICAtiROUMKO-iFPjpwa9CUGqGxR-eEyu--z2JX75MsXvut3rkmQ504AsTcXkYqTtxWzwDYAJNs9iW0HAhQ_5zxJkKhTTr07SaVIuRBiOMTWM4CpxVo3N_L7HfGj6gTd_tk1-q526kNRdI6sVlvTa5eGvkwVTbJDlh6pavkk4istPPqbv3tB6T6NhoSE7B1cZOCIjr406Qx4KaJux8XqNktd4i_S7V8-da78SSvAVxOsJiuhkTAcmNXGQKR0zZROR0VAxrrlJc8aVDSxjQR5RZAyMVKq14BbgE-WRCaNtslgMC7NLvDSh2uSZsmGOXGJZxrWxCkCKtoIKy1qE1jaSqmIRRzGLNznjP0a7SrCrdHaVtEXOmndGJYfGn6tPatNLcHWsX2SFGU7HMkxS4eQ8eYvslEfR7IcDv5A5wtt87pCaBUijPf-keB04Om0BvznwjxY5r49TVvd4_Mdn7v1v-TFZ7l125f3N490-WQmd12EX4QFZBD8wh4BsJvmRc95P5a3tOg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Spectrum+of+Spondyloarthritis+Among+Chinese+Populations&rft.jtitle=Current+rheumatology+reports&rft.au=Zhang%2C+Shangzhu&rft.au=Peng%2C+Linyi&rft.au=Li%2C+Qingyang&rft.au=Zhao%2C+Jinwei&rft.date=2022-08-01&rft.issn=1523-3774&rft.eissn=1534-6307&rft.volume=24&rft.issue=8&rft.spage=247&rft.epage=258&rft_id=info:doi/10.1007%2Fs11926-022-01079-1&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11926_022_01079_1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1523-3774&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1523-3774&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1523-3774&client=summon